The market for vasculitis across the globe is expected to propel significantly during the forecast period. The factors driving the vasculitis market are rising incidences of metabolic disorders and circulatory diseases such as peripheral arterial disease (PAD) and high demand for minimally invasive procedures. In addition, the rising healthcare expenditure and R&D vasculitis treatment and supportive reimbursement policies are estimated to impact the market positively during the forecast period.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/vasculitis-market
Due to the advancement in the treatment, vasculitis can be controlled and now it can be completely cured. However, the side effect associated to treatment such as weight gain, diabetes and bone thinning are now serious issue. Many researches are going on to identify the main cause of vasculitis and various research institutes are providing funds for these researches. For instance, University of Cambridge have received funding from Arthritis Research UK to investigate cause of disease called ANCA-associated vasculitis.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/vasculitis-market
MARKET SEGMENTATION
GLOBAL VASCULITIS MARKET, BY TYPE
LARGE VESSELS
- BEHÇET’S DISEASE
- COGAN’S SYNDROME
- GIANT CELL ARTERITIS (TEMPORAL ARTERITIS)
- POLYMYALGIA RHEUMATICA
- TAKAYASU’S ARTERITIS (AORTIC ARCH SYNDROME)
MEDIUM VESSELS
- BUERGER’S DISEASE (THROMBOANGIITIS)
- CENTRAL NERVOUS SYSTEM VASCULITIS
- KAWASAKI’S DISEASE (MUCOCUTANEOUS LYMPH NODE DISEASE)
- POLYARTERITIS NODOSA
SMALL VESSELS
- CHURG-STRAUSS SYNDROME (EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS)
- CRYOGLOBULINEMIA VASCULITIS
- IMMUNOGLOBULIN A VASCULITIS
- HYPERSENSITIVITY VASCULITIS (ALLERGIC VASCULITIS, CUTANEOUS VASCULITIS, LEUKOCYTOCLASTIC VASCULITIS)
- MICROSCOPIC POLYANGIITIS
GLOBAL VASCULITIS MARKET, BY DIAGNOSIS TESTS
- BLOOD TEST
- URINE TEST
- IMAGING TEST
- ANGIOGRAPHY
- BIOPSY
- OTHER (ERYTHROCYTE SEDIMENTATION RATE (ESR), C–REACTIVE PROTEIN (CRP), CT SCAN, ANCA TESTS)
GLOBAL VASCULITIS MARKET, BY THERAPEUTIC CLASS
- CORTICOSTEROIDS (SUCH AS PREDNISONE, PREDNISOLONE, AND METHYLPREDNISOLONE)
- IMMUNOSUPPRESSANTS
- BIOLOGICS
GLOBAL VASCULITIS MARKET BY END USERS
- HOSPITALS AND CLINICS
- DIAGNOSIS CENTER
- RESEARCH INSTITUTES
- OTHERS
COMPETITIVE LANDSCAPE
- KEY COMPANY ANALYSIS
- KEY STRATEGY ANALYSIS
REGIONAL ANALYSIS
NORTH AMERICAN
- UNITED STATES
- CANADA
EUROPE
- K
- GERMANY
- ITALY
- SPAIN
- FRANCE
- ROE
ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- ROAPAC
REST OF THE WORLD
COMPANY PROFILES
- ABBVIE INC.
- ABLYNX NV
- AMGEN INC.
- ANTHERA PHARMACEUTICALS‚ INC.
- ASPEN PHARMACARE HOLDINGS LIMITED
- ASTRAZENECA PLC
- BAXTER
- BIOGEN
- BRISTOL-MYERS SQUIBB COMPANY
- CELGENE CORPORATION
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
